Table 1. Demographic Characteristics of Patients Who Received Immune Checkpoint Inhibitors for Metastatic Melanoma.
| Variable | No. (%) | P value | ||
|---|---|---|---|---|
| New CM | Total (n = 2251) | |||
| No (n = 2209) | Yes (n = 42) | |||
| Age, mean (SD), y | 62.7 (14.4) | 66.6 (12.4) | 62.8 (14.4) | .08a |
| Sex | ||||
| Female | 800 (36.2) | 14 (33.3) | 814 (36.2) | .70b |
| Male | 1409 (63.8) | 28 (66.7) | 1437 (63.8) | |
| Race | ||||
| Asian/Indian | 40 (1.8) | 0 | 40 (1.8) | .53c |
| Black | 30 (1.4) | 0 | 30 (1.3) | |
| Native American | 1 (0) | 0 | 1 (0) | |
| White | 2047 (92.7) | 39 (92.9) | 2086 (92.7) | |
| Other | 22 (1.0) | 0 | 22 (1.0) | |
| Patient refused | 62 (2.8) | 3 (7.1) | 65 (2.9) | |
| Unknown | 7 (0.3) | 0 | 7 (0.3) | |
| Ethnicity | ||||
| Hispanic | 44 (2.0) | 0 | 44 (2.0) | .23c |
| Not Hispanic | 2031 (91.9) | 42 (100.0) | 2073 (92.1) | |
| Unknown | 134 (6.1) | 0 | 134 (6.0) | |
| Family history of melanoma | ||||
| No | 1804 (81.7) | 30 (71.4) | 1834 (81.5) | .02b |
| Yes | 360 (16.3) | 10 (23.8) | 370 (16.4) | |
| Unknown | 45 (2.0) | 2 (4.8) | 47 (2.1) | |
Abbreviation: CM, cutaneous melanoma.
a
P value based on t test.
b
P value based on χ2 statistic.
c
P value based on Fisher exact test.